Diplomat Specialty Pharmacy® and Diplomat Specialty Infusion Group® are joining the Optum® family.

To learn more about what this means for you, visit our FAQ pages:

Specialty Pharmacy FAQ  •  Infusion Pharmacy FAQ

CERDELGA®

Cerdelga (eliglustat)

FDA INDICATION: Long-term treatment of adult patients with Gaucher disease Type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test. Package Insert

DISTRIBUTOR: Sanofi Genzyme

ROUTE OF ADMINISTRATION: Oral

FORM: Capsule

DOSAGE AND ADMINISTRATION: 
CYP2D6 EMs or IMs: 84 mg orally twice daily.
CYP2D6 PMs: 84 mg orally once daily.

HOW SUPPLIED: 84 mg hard gelatin capsules.

STORAGE REQUIREMENTS: Store at 68–77°F (20–25°C) with excursions permitted between 59–86°F (15–30°C).

OTHER WEBSITES: cerdelga.comCareConnectPSS.com, GaucherCare.com